diagnosishistopathologymyelomaneoplasmsThe clinical and pathological characteristics of a multiple myeloma in an 8-year-old female German Shepherd dog in Argentina [date not given], which was presented with clinical signs of paraplegy and muscle atrophy in association with kidney disease, are described...
Interferon is another type of immunotherapy. Bone marrow cells and some white blood cells release this hormone-like substance. When it's used as a drug, it can slow the growth of myeloma cells. You might take interferon if you've had treatment and are in remission, which means your doctor...
The multiple myeloma condition center is a comprehensive resource for clinical news and expert insights on multiple myeloma. Read more at OncLive.
urine, imaging, and bone marrow tests. With multiple myeloma, cancerous plasma cells divide and grow inside your bone marrow. Plasma cells are white blood cells that produce antibodies. They're part of your immune system.
Our understanding of this group of disorders is developing at an unprecedented rate, and Multiple Myeloma meets the need among oncologists and hematologists for a clear, timely, and authoritative resource on their biology, diagnosis, and treatment.Similar...
There are computer software programs that will need a new algorithm with a slightly different cocktail for folks with myeloma. Once that is done, we’re very optimistic about getting the test into use, because this type of flow cytometry is widely used at centers across the country and worl...
Multiple myeloma (MM) is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein (M protein), destruction of bone, and displacement of other hematopoietic cell lines. [1] MM is part of a spectrum of diseases ...
Multiple myeloma (MM) is a highly heterogenous disease that exists along a continuous disease spectrum starting with premalignant conditions monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) that inevitably precede MM. Over the past two decades, significant pro...
The treatment of multiple myeloma (MM) continues to evolve rapidly with arrival of multiple new drugs, and emerging data from randomized trials to guide therapy. Along the disease course, the choice of specific therapy is affected by many variables including age, performance status, comorbidities, ...
The diagnosis of multiple myeloma requires increased numbers of immature, abnormal, or atypical plasma cells in the bone marrow; a monoclonal protein in the serum or urine; or characteristic bone lesions. The diagnostic workup in a patient with suspected multiple myeloma should include a complete ...